Michael Croft

23PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersAllergyAutoimmunityMajor global burdens of diseaseInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Nov 26, 2024
Comparison of CD30L and OX40L Reveals CD30L as a Promising Therapeutic Target in Atopic Dermatitis.

Rinkesh K Gupta, Daniela Salgado Figueroa, Ferhat Ay

|Oct 25, 2024
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer.

Michael Croft, Shahram Salek-Ardakani, Carl F Ware

|Jan 18, 2024
OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target.

Michael Croft, Ehsanollah Esfandiari, Camilla Chong

|Mar 23, 2023
Anti-CD3 inhibits circulatory and tissue-resident memory CD4 T cells that drive asthma exacerbations in mice.

Gurupreet S Sethi, Donald T Gracias, Rinkesh K Gupta

Pageof 4